Melanie D. Beaton
London, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
TWSG1 variation identifies a ustekinumab-response phenotype in patients with inflammatory bowel disease.
Journal: Pharmacogenetics and genomics
Published: April 21, 2026
Patients with Crohn's disease achieving transmural healing experience superior long-term outcomes compared with those with endoscopic or radiologic healing alone.
Journal: Inflammatory bowel diseases
Published: December 08, 2025
Combining Cytokine-Related Biomarkers to Better Define Tumor Necrosis Factor-α Antagonist Response in Inflammatory Bowel Disease: An Observational Cohort Study.
Journal: Clinical and translational gastroenterology
Published: August 07, 2025
Day 3 Oxford criteria predict steroid non-response for acute severe ulcerative colitis in the post biologic era.
Journal: Journal of Crohn's & colitis
Published: July 18, 2025
IL23 Receptor Polymorphism Is a Predictor of Anti-Tumour Necrosis Factor-α-Induced Paradoxical Psoriasis in Inflammatory Bowel Disease.
Journal: Alimentary pharmacology & therapeutics
Published: May 28, 2025
Directionality of endoscopic and histologic healing in ulcerative colitis: a prospective pilot study.
Journal: European journal of gastroenterology & hepatology
Published: February 07, 2025
Prevalence of stricturing, penetrating complications and extraintestinal manifestations in inflammatory bowel disease detected on cross-sectional imaging in a tertiary care setting.
Journal: United European gastroenterology journal
Published: April 07, 2024
Endoscopic Skipping, Stricturing, and Penetrating Complications in Crohn's Disease on Tandem Ileo-colonoscopy and Cross-sectional Imaging: A Retrospective Cohort Study.
Journal: Inflammatory bowel diseases
Published: March 31, 2024
Initiation of vedolizumab did not provoke new-onset spondylarthritis in patients with inflammatory bowel disease: A prospective 24-week study with imaging assessments.
Journal: United European gastroenterology journal
Published: March 28, 2024
Infliximab Tissue Concentrations in Patients With Stable Ulcerative Colitis Are Correlated With More Durable Infliximab-associated Disease Remission.
Journal: Inflammatory bowel diseases
Published: October 23, 2023
Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trial.
Journal: BMJ open gastroenterology
Published: July 25, 2023
Long Washout Periods Between Biologics for Inflammatory Bowel Disease Clinical Trials Are Unnecessary: A Canadian Retrospective Cohort Study.
Journal: The American journal of gastroenterology
Published: March 16, 2023
Last Updated: 09/26/2026